In an Australian community-based cohort of dementia-free individuals, we found that higher levels of plasma pTau-217, NfL, and GFAP were associated with poorer cognitive performance (in particular, global cognition, abstract reasoning and memory domains) and were correlated with their CSF counterparts. Here, GFAP is linked to dementia.